Founded in 1999 by a group of passionate researchers, Cell Signaling Technology (CST) has established itself as a major player in the field of antibodies and solutions for scientific research. The company was founded in the United States with a clear objective: to provide scientists with high-quality antibodies, rigorously validated to ensure accurate and reproducible results.
Through its commitment to scientific excellence, CST has developed advanced validation technologies and relies on a team of experts in cell signalling, oncology, neuroscience, immunology and epigenetics. Today, CST is recognised worldwide for its expertise in the development of monoclonal, polyclonal, primary and secondary antibodies, with a wide choice of conjugations and formulations tailored to the needs of researchers.
CST develops antibodies and reagents dedicated to strategic areas of research:
CST antibodies are rigorously validated for a variety of applications, ensuring reproducible and accurate results:
Discover the complete CST range available from Milian and find the right antibody for your needs.
Contact an advisorSearch for antibodies and reagentsMore about
